Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
[GlobeNewswire] – TARRYTOWN, N.Y. — Progenics Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 7,608,696 primary shares of its common stock at a public offering price of $4.60 per … more
View todays social media effects on PGNX
View the latest stocks trending across Twitter. Click to view dashboard